Cancer
01 Jan 2013
Trial of PI-88 with Docetaxel in Advanced Non-Small-Cell Lung Cancer (NSCLC)
PI-88 is a new experimental drug that inhibits tumour growth by reducing the formation of new blood vessels into tumours. Docetaxel is a standard second-line treatment offered to patients with non-small-cell lung cancer who havenât responded to first-line therapies (platinum-based drugs or radiotherapy). Of this group of patients, only 20%…
Cancer
01 Jan 2013
Gemzar Prolongs Survival in Breast Cancer Trial
Eli Lilly and Co’s drug Gemzar should be more widely used to treat advanced breast cancer following a trial in which people taking it and the standard drug paclitaxel lived months longer than those taking paclitaxel alone, a researcher said on Saturday. Official Title Conditions Study Type Study Design Further…
Cancer
01 Jan 2013
The role of gemcitabine in the management of women with locally advanced and metastatic breast cancer
Prof Michael Friedlander Department of Medicine, Prince of Wales Clinical School, Randwick, NSW Cytotoxic chemotherapy plays an important role in the treatment of women with hormone-refractory or hormone-insensitive breast cancer. These agents have demonstrated benefits in providing symptom relief, temporarily reversing or delaying disease progression, and prolonging life1 with…
Cancer
01 Jan 2013
MabThera in aggressive non-Hodgkin’s lymphoma
Study of MabThera in aggressive non-Hodgkin’s lymphoma in patients less than 60 years old halted two years early due to significant efficacy benefits Official Title Conditions Study Type Study Design Further Details Study Start Eligibility & Criteria Total Enrolment Contact Details…
Cancer
01 Jan 2013
Breast Cancer – HER2 Testing Recommendations in Australia
The following is an abstract taken from Taylor and Francis Health Sciences, discussing HER2 testing recommendations in Australia. Official Title Conditions Study Type Study Design Further Details Study Start Eligibility & Criteria Total Enrolment Contact Details…
Cancer
01 Jan 2013
Vaccine Therapy in Treating Patients With Cancer of the Gastrointestinal Tract
Vaccines may make the body build an immune response to kill tumor cells. Vaccines may make the body build an immune response to kill tumor cells.Randomizedphase II trial to compare the effectiveness of two different vaccines in treating patients who have cancer of the gastrointestinal tract. Condition:- Gastrointestinal CancerStudy Type:…
Bone
01 Jan 2013
Combination Chemotherapy and Peripheral Stem Cell Transplantation With or Without Radiation Therapy and/or Surgery in Treating Patients With Ewing’s Sarcoma
RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. Radiation therapy uses high-energy x-rays to damage tumor cells. Peripheral stem cell transplantation may allow the doctor to give higher doses of chemotherapy and kill more tumor cells. It is…
Cancer
01 Jan 2013
Bevacizumab to Treat Inflammatory Breast Cancer
This study will evaluate the effectiveness of the drug bevacizumab, in combination with doxorubicin and docetaxel, in improving survival of patients with inflammatory breast cancer. This aggressive breast cancer, which often causes a red, swollen, tender breast, is associated with a poor prognosis. Bevacizumab blocks the growth of new blood…
Cancer
01 Jan 2013
GW572016 For Treatment Of Refractory Metastatic Breast Cancer
The purpose of this study is to determine the efficacy of an oral dual kinase inhibitor for the treatment of metastatic breast cancer tumors that are known to overexpress ErbB2 in a refractory patient population. Official Title Conditions – Metastatic breast cancer Study Type Interventional Study Design Treatment, Non-Randomized, Open…
